China's 2026-2030 health plan
Analysis based on 8 articles · First reported Jul 13, 2026 · Last updated Jul 21, 2026
The plan signals increased government spending on healthcare infrastructure, digital health, and innovative drugs, benefiting domestic pharmaceutical and medical device companies. It also supports the growth of AI and biotech sectors, potentially attracting investment.
China's State Council issued a national health plan for the 15th Five-Year Plan period (2026-2030), aiming to raise average life expectancy to 80 years by 2030 from 79.25 years in 2025. The plan outlines measures to expand fair access to healthcare, promote proactive health management, and bring core health indicators in line with high-income economies. It emphasizes life-cycle health services, including smoking reduction, fertility support, cancer screening, HPV vaccination, elderly care, and occupational health. The plan also calls for building a national smart healthcare platform, leveraging AI to upgrade the pharmaceutical industry chain, and deepening international health cooperation under the Belt and Road Initiative. It targets 0.7 rehabilitation physicians and 1.6 rehabilitation therapists per 10,000 people by 2030, and aims to reduce the smoking rate among those aged 15 and above to 20%.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard